Wells Fargo & Company Cerus Corp Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Cerus Corp stock. As of the latest transaction made, Wells Fargo & Company holds 94,881 shares of CERS stock, worth $218,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,881
Previous 79,844
18.83%
Holding current value
$218,226
Previous $172,000
4.07%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CERS
# of Institutions
156Shares Held
142MCall Options Held
39.6KPut Options Held
60.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.9MShares$45.8 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$44.8 Million0.47% of portfolio
-
Black Rock Inc. New York, NY13.6MShares$31.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$23 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$19.7 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $407M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...